Category Archives: Treatment as Prevention

Studies show “Real World,” benefits of HIV treatment: It reduces likelihood of HIV transmission in communities, ups overall life expectancy

By on .

First the landmark HPTN 052 study proved what antiretroviral treatment can do to prevent transmission of HIV. Now, two studies reported in the most recent edition of the journal Science spell out what increased treatment coverage has done, in communities in the “real world” — among people going about their business, not receiving instructions of […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]

HIV’s impact on men who have sex with men “can no longer be ignored”

By on .

More than 30 years into the epidemic that was first documented among gay men in America, a disturbing trend is being noted globally: Where rates of new HIV infections are going down among other populations, they are rising among men who have sex with men. “The epidemics are going in different directions,” said Chris Beyrer […]

WHO documents summarize current guidelines, progress, next steps, and pitfalls

By on .

Remember when one of the objections to rolling out life-saving treatment to people living with HIV in developing countries was that lack of capacity to maintain treatment would lead to drug resistance on a massive scale? While that didn’t happen at the scary levels projected, the transmission of drug resistant strains of HIV continue to […]

Subsequent HPTN 052 data shows early HIV treatment is even more beneficial to patient, cost-effective

By on .

The good news keeps getting better for the HIV Prevention Trials Network (HPTN) 052 study, which found last year that HIV-infected persons on antiretroviral therapy (ART) were 96 percent less likely to transmit the virus to an uninfected partner through vaginal sex. At the International AIDS Conference (IAC) in Washington this week, two late-breaker sessions […]

The potential of HIV Treatment as Prevention among drug users

By on .

Of the nearly 16 million injection drug users worldwide, approximately 3 million are living with HIV.  And if sub-Saharan Africa is excluded, thirty percent of global HIV cases are attributed to injection drug use and in some cases is the main means of HIV transmission. Dr. Nora Volkow, director of the National Institute on Drug […]

Analysis looks at fiscal savings, human toll

By on .

Unless Congress finds ways to lower the federal deficit by $1.2 trillion in the next five months,  the law passed last year mandating across-the-board cuts to nearly all budget items will reduce current global health spending by about 10 percent of its current level, an analysis by the Foundation for AIDS Research (amfAR) estimates. The […]

WHO’s HIV/TB update latest move toward treatment as prevention

By on .

The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health […]

Beginning to End the AIDS Epidemic: What’s the Research Agenda?

By on .

Capitol Hill briefing highlights research agenda to end AIDS

The following is a guest blog post by Chris Collins, vice president and director of Public Policy at the Foundation for AIDS Research (amfAR) and Mitchell Warren, executive director of AVAC.

Looking back over three decades of AIDS, it’s hard to point to a better investment than research. Over the past three years, a string of HIV prevention research breakthroughs has put the ambitious goal of even talking about an end of AIDS within sight for the first time. With more strategic use of the tools we have today, we can bend the curve of new infections…

Breaking News: House committee approves 2013 funding for PEPFAR, Global Fund, global TB

By on .

The House Appropriations Committee voted on its fiscal year (FY) 2013 State and Foreign Operations Appropriations bill Wednesday and released a report that clarifies its funding intentions for key global health programs.  The bill includes $5.542 billion for global AIDS funding through the State Department, and the report specifies $4.243 billion to support the U.S. […]